Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes

Journal of Cellular Physiology

Volumn 230, Issue 11, 2015, Pages 2706-2717

  Zhao, Shuhua ^a   Zhang, Yuanyuan ^a   Zheng, Xiuxiu ^a   Tu, Xiaolong ^a   Li, Huanan ^a   Chen, Jiangning ^a   Zang, Yuhui ^a   Zhang, Junfeng ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 101; TRANSCRIPTION FACTOR ZEB1; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; 3' UNTRANSLATED REGION; CADHERIN; HOMEODOMAIN PROTEIN; MICRORNA; MIRN101 MICRORNA, HUMAN; TRANSCRIPTION FACTOR; ZEB1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; HEPATOCELLULAR CARCINOMA CELL LINE; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WOUND HEALING; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; METASTASIS; PATHOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; CADHERINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; HOMEODOMAIN PROTEINS; HUMANS; LIVER NEOPLASMS; MICRORNAS; NEOPLASM METASTASIS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84937888790     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24995     Document Type: Article

References (40)

1. Brabletz S, Brabletz T. 2010. The ZEB/miR-200 feedback loop: A motor of cellular plasticity in development and cancer? EMBO Rep 11:670-677.
2. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, Goodall GJ. 2008. Double-Negative Feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 68:7846-7854.
3. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA. 2000. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2:76-83.
4. Chen CZ. 2005. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353:1768-1771.
5. Cho IJ, Kim YW, Han CY, Kim EH, Anderson RA, Lee YS, Lee CH, Hwang SJ, Kim SG. 2010. E-cadherin antagonizes transforming growth factor β1 gene induction in hepatic stellate cells by inhibiting RhoA-dependent Smad3 phosphorylation. Hepatology 52:2053-2064.
6. Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, Nakshatri H. 2007. NF-kappaB represses Ecadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: Potential involvement of ZEB-1 and ZEB-2. Oncogene 26:711-724.
7. Cicchini C, Amicone L, Alonzi T, Marchetti A, Mancone C, Tripodi M. 2015. Molecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte. Liver Int 35:302-310.
8. Croce CM, Calin GA. 2005. miRNAs, cancer, and stem cell division. Cell 122: 6-7.
9. Dillner NB, Sanders MM. 2002. Upstream stimulatory factor (USF) is recruited into a steroid hormonetriggered regulatory circuit by the estrogen-inducible transcription factor delta EF1. J Biol Chem 277:33890-33894.
10. Dooley S, Hamzavi J, Ciuclan L, Godoy P, Ilkavets I, Ehnert S, Ueberham E, Gebhardt R, Kanzler S, Geier A, Breitkopf K, Weng H, Mertens PR. 2008. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology 135:642-659.
11. Giordano S, Columbano A. 2013. MicroRNAs: New tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology 57:840-847.
12. Grant-Rowe1 R, Lin YS, Shimizu-Hirota R, Hanada S, Neilson EG, Greenson JK, Weiss SJ. 2011. Hepatocyte-derived Snail1 propagates liver fibrosis progression. Mol Cell Biol 31:2392-2403.
13. Gumbiner BM. 2005. Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol 6:622-634.
14. Hashiguchi M, Ueno S, Sakoda M, Iino S, Hiwatashi K, Minami K, Ando K, Mataki Y, Maemura K, Shinchi H, Ishigami S, Natsugoe S. 2013. Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC). BMC Cancer 13:572.
15. Hu F, Wang C, Guo S, Sun W, Mi D, Gao Y, Zhang J, Zhu T, Yang S. 2011. δEF1 promotes osteolytic metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression. Biochim Biophys Acta 1809:200-210.
16. Kaimori A, Potter J, Kaimori JY, Wang C, Mezey E, Koteish A. 2007. Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem 282:22089-22101.
17. Kalluri R, Weinberg RA. 2009. The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420-1428.
18. Korpal M, Lee ES, Hu G, Kang Y. 2008. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283:14910-14914.
19. Liu J, Zhang Z, Tu X, Liu J, Zhang H, Zhang J, Zang Y, Zhu J, Chen J, Dong L, Zhang J. 2013. Knockdown of N-acetylglucosaminyl transferase V ameliorates hepatotoxin-induced liver fibrosis in mice. Toxicol Sci 135:144-155.
20. Meindl-Beinker NM, Dooley S. 2008. Transforming growth factor beta and hepatocyte transdifferentiation in liver fibrogenesis. J Gastroenterol Hepatol 23:S122.
21. Nakagawa H, Hikiba Y, Hirata Y, Font-Burgada J, Sakamoto K, Hayakawa Y, Taniguchi K, Umemura A, Kinoshita H, Sakitani K, Nishikawa Y, Hirano K, Ikenoue T, Ijichi H, Dhar D, Shibata W, Akanuma M, Koike K, Karin M, Maeda S. 2014. Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis. Proc Natl Acad Sci USA 111:1090-1095.
22. Nittta T, Kim JS, Mohuczy D, Behrns KE. 2008. Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and laterations in survival signaling pathways. Hepatology 48:909-919.
23. Omenetti A, Porrello A, Jung Y, Yang L, Popov Y, Choi SS, Witek RP, Alpini G, Venter J, Vandongen HM, Syn WK, Baroni GS, Benedetti A, Schuppan D, Diehl AM. 2008. Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest 118:3331-3342.
24. Park SM, Gaur AB, Lengyel E, Peter ME. 2008. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22:894-907.
25. Peinado H, Olmeda D, Cano A. 2007. Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nat Rev Cancer 7:415-428.
26. Postigo AA, Depp JL, Taylor JJ, Kroll KL. 2003. Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins. The EMBO J 22:2453-2462.
27. Sánchez-Tilló E, Siles L, de Barrios O, Cuatrecasas M, Vaquero EC, Castells A, Postigo A. 2011. Expanding roles of ZEB factors in tumorigenesis and tumor progression. Am J Cancer Res 1:897-912.
28. Schmalhofer O, Brabletz S, Brabletz T. 2009. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 28:151-166.
29. Seki E, De Minicis S, Inokuchi S, Taura K, Miyai K, Van Rooijen N, Schwabe RF, Brenner DA. 2009. CCR2 promotes hepatic fibrosis in mice. Hepatology 50:185-197.
30. Singh A, Settleman J. 2010. EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer. Oncogene 29:4741-4751.
31. Syn WK, Jung Y, Omenetti A, Abdelmalek M, Guy CD, Yang L, Wang J, Witek RP, Fearing CM, Pereira TA, Teaberry V, Choi SS, Conde-Vancells J, Karaca GF, Diehl AM. 2009. Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. Gastroenterology 137:1478-1488.
32. Tao Z, Wan J, Zeng L, Xie L, Sun H, Qin L, Wang L, Zhou J, Ren Z, Li Y, Fan J, Wu W. 2013. miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma. J Exp Med 210:789-803.
33. Thiery JP, Acloque H, Huang RY, Nieto MA. 2009. Epithelial-mesenchymal transitions in development and disease. Cell 139:871-890.
34. Tu X, Zhang H, Zhang J, Zhao S, Zheng X, Zhang Z, Zhu J, Chen J, Dong L, Zang Y, Zhang J. 2014. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway. J Pathol 234:46-59.
35. Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B, Laxman B, Cao X, Jing X, Ramnarayanan K, Brenner JC, Yu J, Kim JH, Han B, Tan P, Kumar-Sinha C, Lonigro RJ, Palanisamy N, Maher CA, Chinnaiyan AM. 2008. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322:1695-1699.
36. Wang L, Zhang X, Jia LT, Hu SJ, Zhao J, Yang JD, Wen WH, Wang Z, Wang T, Zhao J, Wang RA, Meng YL, Nie YZ, Dou KF, Chen SY, Yao LB, Fan DM, Zhang R, Yang AG. 2013. C-Myc-mediated epigenetic silencing of microRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma. Hepatology 59:1850-1863.
37. Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, Tanjore H, Kalluri R. 2007a. Fibroblasts. derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282:23337-23347.
38. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR. 2007b. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13:952-961.
39. Zhai B, Yan HX, Liu SQ, Chen L, Wu MC, Wang HY. 2008. Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas. World J Gastroenterol 14:5665-5673.
40. Zhang J, Zhang H, Liu J, Tu X, Zang Y, Zhu J, Chen J, Dong L, Zhang J. 2012. MiR-30 inhibits TGF-β1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting Snail1. Biochem Biophys Res Commun 417:1100-1105.